Leads Biolabs
Latest round
- Series C
Last raised
- Oct 2021
Total raised
- $145M
Investors
- 25
About Leads Biolabs
a. Leads Biolabs is an antibody-drug developer and engaged in research and development of original antibody drugs for anti-tumor, treatment of infectious diseases or autoimmune, and more., Nanjing Venture Capital, New Silk Road Investment, and Shanghai Zhuangzhong Venture Investment. Leads Biolabs provides an Antibody Discovery platform and Dual Multispecific Antibody platform. The Antibody Discovery platform integrates and utilizes internal and external discovery platforms to discover antibodies in combination with development progress, target characteristics, and required multispecies antibody design. The Dual Multispecific Antibody platform provides MOA or synthetic molecules by combining different targets. In addition, the company offers ADCC and CDC enhanced antibodies, process cell strains, vitro drug efficacy assessment and CMC. ADCC and CDC enhanced antibodies are molecules with better CDC and ADC effects compared to commercial antibodies. Leads Biolabs has several products in the clinical stage, including LBL-007 (LAG-3 monoantiob), LBL-003 (TIM-3 monoantiob), LBL-015 (PD-1/TGF beta dual resistance), and LBL-024 (PD-L1/4-1BB dual resistance).,Ltd.
Who invested in Leads Biolabs
25 investors across 5 rounds
See all investors in Leads Biolabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leads Biolabs
Who invested in Leads Biolabs?
Leads Biolabs has 25 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leads Biolabs raised?
Leads Biolabs has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Leads Biolabs last raise money?
Leads Biolabs's most recent round on record is a Series C, in Oct 2021.
What does Leads Biolabs do?
Leads Biolabs is a biotechnology company.
Where is Leads Biolabs headquartered?
Leads Biolabs is headquartered in Nanjing, China.
Which VCs invest in companies like Leads Biolabs?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Leads Biolabs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Leads Biolabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.